From the announcement today:
Effectuation of the DOCA and completion of the Share Sale Agreement remain subject to Pilbara Minerals completing a A$240 million equity raising, which, as previously announced, will comprise:
• a A$119 million placement to AustralianSuper Pty Ltd in its capacity as trustee for AustralianSuper and Resource Capital Fund VII L.P. (“Placement”; and
• a A$121 million fully underwritten accelerated non-renounceable entitlement offer (“Entitlement Offer”,
each at a price of A$0.36 per share (together, the “Equity Raising”. The offer price was set on the announcement of Pilbara Mineralogys’ entry into the Implementation Deed on 28 October 2020.
The Placement process will commence today, with the Entitlement Offer expected to launch early next week following completion of the Placement. Further details on its timing will be provided when the Entitlement Offer is launched.
Upon the release of this announcement, the Company requests the reinstatement of trading of its securities.
Release authorised by Ken Brinsden, Pilbara Minerals Limited’s Managing Director.
- Forums
- ASX - By Stock
- Ann: Trading Halt
From the announcement today: Effectuation of the DOCA and...
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.02 |
Change
-0.040(1.31%) |
Mkt cap ! $9.090B |
Open | High | Low | Value | Volume |
$3.08 | $3.11 | $3.02 | $55.82M | 18.22M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 424619 | $3.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.03 | 17344 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 329137 | 3.020 |
23 | 502241 | 3.010 |
92 | 359053 | 3.000 |
16 | 98735 | 2.990 |
19 | 101042 | 2.980 |
Price($) | Vol. | No. |
---|---|---|
3.040 | 32598 | 6 |
3.050 | 109743 | 7 |
3.060 | 104622 | 7 |
3.070 | 137237 | 8 |
3.080 | 1849 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online